Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (9): 53-58.doi: 10.6040/j.issn.1671-7554.0.2021.1471

Previous Articles     Next Articles

Effects of tanshinone IIA on the proliferation and apoptosis of endometrial carcinoma cells

ZHAO Ge1, ZOU Cunhua1, SONG Dongdong2, ZHAO Shuping1   

  1. 1. Gynecological Center;
    2. General Surgery Qingdao Women and Children Hospital, Qingdao 266034, Shandong, China
  • Published:2022-09-02

Abstract: Objective To investigate the effects of tanshinone IIA on the proliferation and apoptosis of endometrial carcinoma cells. Methods According to the experimental requirements, endometrial carcinoma cells treated with tanshinone IIA were divided into the control group, low concentration group(1 μg/mL), medium concentration group(2.5 μg/mL)and high concentration group(5 μg/mL). Meanwhile, cells co-treated with CK2 specific phosphorylation inhibitor(TBB)and tanshinone IIA were divided into the control group, TBB group(60 μmol), drug group(5 μg/mL)and drug(5 μg/mL)+ TBB group(60 μmol). The effects of tanshinone IIA on the proliferation of cells were detected with crystal violet staining; expressions of P53, Cleaved caspase-3, B-cell lymphoma-2(Bcl-2), casein kinase 2α(CK2α), deletion in breast cancer 1(DBC1), silent information regulator 1(SIRT1)and p-deletion in breast cancer 1(p-DBC1)were detected with Western blotting. After TBB was added, expressions of CK2α, DBC1 and p-DBC1 were also detected. Results The results of crystal violet staining showed that the proliferation rates of the control group and high concentration group at each time point(24 h, 48 h, 72 h)were(0.87±0.05)%,(0.61±0.04)%,(0.30±0.04)% and(0.09±0.04)%, respectively(F=217.976, P<0.001). The results of Western blotting showed that under the action of tanshinone IIA, the expressions of P53(F=244.261)and Cleaved caspase-3(F=290.842)increased in a concentration-dependent manner, while the expression of Bcl-2(F=198.170)decreased in a concentration-dependent manner(P<0.001), and the expression of p-DBC1/DBC1 decreased in a concentration-dependent manner(F=187.092, P<0.001), but there was no significant difference in CK2α and SIRT1 expressions(P>0.05). The expression of p-DBC1/DBC1 was inhibited by TBB(F=7.847), tanshinone IIA(F=827.715)and their combination(F=22.174), and the difference was statistically significant compared with the control group(P=0.023,P<0.001, P=0.002), but there was no significant difference in CK2α expression(P>0.05). Conclusion Tanshinone IIA can significantly inhibit the proliferation and induce apoptosis of endometrial carcinoma cells, and the mechanism may be related to the CK2/DBC1/SIRT1/P53 signaling pathway.

Key words: Tanshinone IIA, Endometrial carcinoma, Apoptosis, Cell proliferation, Phosphorylation

CLC Number: 

  • R737.33
[1] Urick ME, Bell DW. Clinical actionability of molecular targets in endometrial cancer[J]. Nat Rev Cancer, 2019, 19(9): 510-521.
[2] 魏静, 张为远. 早期子宫内膜癌患者药物治疗中存在的问题[J]. 中国妇产科临床杂志, 2019, 20(1): 87-89. WEI Jing, ZHANG Weiyuan. Problems in drug treatment of patients with early endometrial cancer[J]. Chinese Journal of Obstetrics and Gynecology, 2019, 20(1): 87-89.
[3] Wortman BG, Nout RA, Bosse T, et al. Selecting adjuvant treatment for endometrial carcinoma using molecular risk factors[J]. Curr Oncol Rep, 2019, 21(9): 83. doi: 10.1007/s11912-019-0825-z.
[4] Zhou M, Zhou G, Hu SH, et al. Tanshinone IIA suppress the proliferation of HNE-1 nasopharyngeal carcinoma an in vitro study[J]. Saudi J Biol Sci, 2018, 25(2): 267-272.
[5] International BMR. Retracted: tanshinone IIA induces apoptosis in human oral cancer KB cells through a mitochondria-dependent pathway[J]. Biomed Res Int, 2017: 9496485. doi: 101155/2017/9496485.
[6] Jeon YJ, Kim JS, Hwang GH, et al. Inhibition of cytochrome P4502J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells[J]. Eur J Pharmacol, 2015, 764: 480-488. doi: 10.1016/j.ejphar.2015.07.047.
[7] Lin JY, Ke YM, Lai JS, et al. Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells[J]. Phytomedicine, 2015, 22(10): 929-938.
[8] Lin H, Zheng L, Li S, et al. Cytotoxicity of tanshinone IIA combined with taxol on drug-resist breast cancer cells MCF-7 through inhibition of tau[J]. Phytother Res, 2018, 32(4): 1-5.
[9] Dong W, Zhang Y, Chen X, et al. High-dose tanshinone IIA suppresses migration and proliferation while promoting apoptosis of astrocytoma cells via notch-1 pathway[J]. Neurochem Res, 2018, 43(9): 1855-1861.
[10] Su CC. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway[J]. Int J Mol Med, 2018, 41(4): 2389-2396.
[11] 鲁强, 管东方, 吴艳丽, 等. 靶向调控SIRT1基因表达对子宫内膜癌细胞生物学行为的影响及其机制研究[J]. 中国妇产科临床杂志, 2021, 22(3): 261-263. LU Qiang, GUAN Dongfang, WU Yanli, et al. Effect of targeting SIRT1 gene expression on biological behavior of endometrial cancer cells and its mechanism[J]. Chinese Journal of Obstetrics and Gynecology, 2021, 22(3): 261-263.
[12] Genestie C, Leary A, Devouassoux M, et al. Histological and molecular classification of endometrial carcinoma and therapeutical implications[J]. Bull Cancer, 2017, 104(12): 1001-1012.
[13] Psilopatis I, Pergaris A, Giaginis C, et al. Histone deacetylase inhibitors: a promising therapeutic alternative for endometrial carcinoma[J]. Dis Markers, 2021: 7850688. doi: 10.1155/2021/7850688.
[14] Huvila J, Pors J, Thompson EF, et al. Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis[J]. J Pathol, 2021, 253(4): 355-365.
[15] Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: Treating cancer with specificity[J]. Eur J Pharmacol, 2018, 834: 188-196. doi: 10.1016/j.ejphar.2018.07.034.
[16] Wang Z, Meng F, Zhong Z. Emerging targeted drug delivery strategies toward ovarian cancer[J]. Adv Drug Deliv Rev, 2021, 178: 113969. doi: 10.1016/j.addr.2021.113969.
[17] Fang ZY, Zhang M, Liu JN, et al. Tanshinone IIA: a review of its anticancer effects[J]. Front Pharmacol, 2021, 11: 611087. doi: 10.3389/fphar.2020.611087.
[18] Jalal T, Natto HA, Wahab RA. Cytotoxicity and toxicological studies of artocarpus altilis extracts, inducing apoptosis and cell cycle arrest via caspase-3 and caspase-8 pathways against human breast MCF-7 cells[J]. Comb Chem High Throughput Screen, 2022, 25(6): 973-985.
[19] Ghaffari K, Ahmadi R, Saberi B, et al. Anti-proliferative effects of Ziziphus spina-christi and Phlomis russeliana leaf extracts on HEK293 and MCF-7 Cell Lines and Evaluation of Bax and Bcl-2 Genes Expression Level in MCF-7 Cells[J]. Asian Pac J Cancer Prev, 2021, 22(S1): 81-87.
[20] Li W, Li F, Zhang X, et al. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment[J]. Signal Transduct Target Ther, 2021, 6(1): 422. doi: 10.1038/s41392-021-00825-8.
[21] Fang Q, Bellanti JA, Zheng SG. Advances on the role of the deleted in breast cancer(DBC1)in cancer and autoimmune diseases[J]. J Leukocyte Biol, 2021, 109(2): 449-454.
[22] Brandl L, Zhang Y, Kirstein N, et al. Targeting c-MYC through interference with NAMPT and SIRT1 and their association to oncogenic drivers in murine serrated intestinal tumorigenesis[J]. Neoplasia, 2019, 21(10): 974-988.
[23] Yin CF, Kao SC, Hsu CL, et al. Phosphoproteome analysis reveals dynamic heat shock protein 27 phosphorylation in tanshinone IIA-induced cell death[J]. J Proteome Res, 2020, 19(4): 1620-1634.
[24] Tang S, Yuan Y, Liu Z, et al. Casein kinase 2 inhibitor CX-4945 elicits an anti-Warburg effects through the downregulation of TAp73 and inhibits gastric tumorigenesis[J]. Biochem Biophys Res Commun, 2020, 530(4): 686-691.
[25] Li L, Feng R, Fei S, et al. NANOGP8 expression regulates gastric cancer cell progression by transactivating DBC1 in gastric cancer MKN-45 cells[J]. Oncol Lett, 2019, 17(1): 555-563.
[26] Jung M, Park KH, Kim HM, et al. Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer[J]. Gastric Cancer, 2019, 22(6):1153-1163.
[1] LU Xiang-Dong, YANG Wei, XU Guang-Meng, QU Yuan-Ming. Expression and role of PPAR-γin meningiomas and troglitazone induced meningiomas cell apoptosis in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 65-.
[2] LIU Teng, MA Yingchun. Expression of ECT2 in uterine corpus endometrial carcinoma and its clinical significance based on bioinformatics database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 63-71.
[3] LIU Min, ZHANG Yuchao, MA Xiaoli, LIU Xinyu, SUN Lu, ZUO Dan, LIU Yuantao. Effects of orphan nuclear receptor NR4A1 on H2O2 induced injury of mouse renal podocytes [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 16-21.
[4] FENG Haigang, LIU Guowen, CAO Hong. Effects and mechanism of interfering MAD2L1 gene expression on the apoptosis of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 9-16.
[5] LI Hui, JIANG Chaoyang, LIU Yan, ZHANG Man. Effects and mechanism of histone deacetylase SIRT1 controlled macrophage apoptosis induced by oxidized low density lipoprotein [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 6-12.
[6] LU You, QIE Di, WU Jinhui, YANG Fan. Effects of the intervention of Sonic Hedgehog signaling pathway on learning and memory ability in rats with intrauterine growth restriction [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 82-89.
[7] DING Fei, JIANG Jie. Effects of curcumin on progesterone resistance in endometrial carcinoma [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 35-41.
[8] NAN Li, YANG Kaizhuan, ZHANG Yifan. Effects of domestic white light-emitting diodes exposure on rat retina [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 56-62.
[9] LIU Shudan, ZHANG Feiyan, GUO Songlin, LIANG Xueyun, CHEN Dongmei. Oxymatrine ameliorates oxidative stress injury of HaCaT cells induced by hypoxia ischemia [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 26-34.
[10] XUE Yuan, LIN Xueyan, XU Ge, TIAN Yongjie. Expression of hypoxia-inducible factor-1α in the serum of patients with endometriosis and its effect on epithelial mesenchymal transition of eutopic endometrial stromal cells [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 41-47.
[11] WANG Zhengyang, XIA Yan, SHI Kaixuan, TAO Kun, WANG Xiaojie. Effects of Trametinib on PAX8 expression in ovarian cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 25-31.
[12] DU Tiantian, LI Juan, ZHAO Yinghui, DUAN Weili, WANG Jing, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression profiles of long non-coding RNA LINC02474 and effects on cell proliferation in colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 59-69.
[13] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32-37.
[14] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7-14.
[15] WANG Bingyu, YANG Yang, CHAO Lan. Expression and role of toll-like receptor 4 in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 47-52.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7 -14 .
[2] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24 -31 .
[3] LONG Tingting, XIE Ming, ZHOU Lu, ZHU Junde. Effect of Noggin protein on learning and memory abilities and the dentate gyrus structure after cerebral ischemia reperfusion injury in mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 15 -23 .
[4] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38 -46 .
[5] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32 -37 .
[6] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1 -6 .
[7] XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53 -59 .
[8] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
[9] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60 -66 .
[10] XU Jixi, CHEN Weijian. Diffuse midline glioma with H3 K27M mutation in the spinal cord: a case report[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 96 -101 .